UNSPSC 51102868: Nystatin/triamcinolone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102868 Nystatin/triamcinolone, a Commodity code, nominally describes a specific pharmaceutical combination product, but recent state and local procurement activity under this code shows little alignment with that scope. The Illinois Department of Public Health's August 2026 piggyback pharmaceutical contract through MMCAP Infuse awarded to Chartwell Rx LLC covered Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—neither of which is nystatin/triamcinolone. Seminole County, Florida's June 2026 IFB for Naloxone and Safe Drug Deactivation Systems further diverges from the code's stated product line. State and local agencies appear to be using this code as a catch-all pharmaceutical procurement tag rather than restricting use to the specific nystatin/triamcinolone formulation the code nominally represents. The issuing bodies in recent activity span state health departments and county public health entities, suggesting that pharmaceutical supply contracts flow through both state-level departments and regional county health systems.

Recent activity is geographically sparse, with documented opportunities originating in Illinois and Florida. The Illinois Department of Public Health's contract represents a completed award with a $2,999,999.11 total value over three years including renewal periods, awarded under an Invitation for Bid (IFB) through cooperative purchasing. Seminole County's procurement, posted June 30, 2026, with a July 26, 2023 response date, sought annual supplies of 1,900 Naloxone units and 800 Safe Drug Deactivation Systems with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, also structured as a competitive IFB. Both procurements emphasize volume purchasing through established cooperative vehicles and multi-year terms with renewal options. The code shows limited recent solicitation activity and the products actually being purchased diverge substantially from the code's nominal scope, signaling potential misclassification in state procurement systems or an unexpectedly broad use of this commodity code across pharmaceutical categories.